
Medistim ASA
OSE:MEDI


to continue MEDI research
to continue MEDI research
You've reached your weekly stock limit.
Sign UpMedistim ASA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
132
213
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Medistim ASA hold over its rivals?
What risks and challenges
does Medistim ASA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Medistim ASA.
Provide an overview of the primary business activities
of Medistim ASA.
What unique competitive advantages
does Medistim ASA hold over its rivals?
What risks and challenges
does Medistim ASA face in the near future?
Summarize the latest earnings call
of Medistim ASA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Medistim ASA.
Provide P/S
for Medistim ASA.
Provide P/E
for Medistim ASA.
Provide P/OCF
for Medistim ASA.
Provide P/FCFE
for Medistim ASA.
Provide P/B
for Medistim ASA.
Provide EV/S
for Medistim ASA.
Provide EV/GP
for Medistim ASA.
Provide EV/EBITDA
for Medistim ASA.
Provide EV/EBIT
for Medistim ASA.
Provide EV/OCF
for Medistim ASA.
Provide EV/FCFF
for Medistim ASA.
Provide EV/IC
for Medistim ASA.
Show me price targets
for Medistim ASA made by professional analysts.
What are the Revenue projections
for Medistim ASA?
How accurate were the past Revenue estimates
for Medistim ASA?
What are the Net Income projections
for Medistim ASA?
How accurate were the past Net Income estimates
for Medistim ASA?
What are the EPS projections
for Medistim ASA?
How accurate were the past EPS estimates
for Medistim ASA?
What are the EBIT projections
for Medistim ASA?
How accurate were the past EBIT estimates
for Medistim ASA?
Compare the revenue forecasts
for Medistim ASA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Medistim ASA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Medistim ASA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Medistim ASA compared to its peers.
Compare the P/E ratios
of Medistim ASA against its peers.
Discuss the investment returns and shareholder value creation
comparing Medistim ASA with its peers.
Analyze the financial leverage
of Medistim ASA compared to its main competitors.
Show all profitability ratios
for Medistim ASA.
Provide ROE
for Medistim ASA.
Provide ROA
for Medistim ASA.
Provide ROIC
for Medistim ASA.
Provide ROCE
for Medistim ASA.
Provide Gross Margin
for Medistim ASA.
Provide Operating Margin
for Medistim ASA.
Provide Net Margin
for Medistim ASA.
Provide FCF Margin
for Medistim ASA.
Show all solvency ratios
for Medistim ASA.
Provide D/E Ratio
for Medistim ASA.
Provide D/A Ratio
for Medistim ASA.
Provide Interest Coverage Ratio
for Medistim ASA.
Provide Altman Z-Score Ratio
for Medistim ASA.
Provide Quick Ratio
for Medistim ASA.
Provide Current Ratio
for Medistim ASA.
Provide Cash Ratio
for Medistim ASA.
What is the historical Revenue growth
over the last 5 years for Medistim ASA?
What is the historical Net Income growth
over the last 5 years for Medistim ASA?
What is the current Free Cash Flow
of Medistim ASA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Medistim ASA.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
NO |
![]() |
Medistim ASA
OSE:MEDI
|
3.7B NOK | 21.9 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
234.3B USD | 22.5 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
187.2B USD | 60.9 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
147.1B USD | 34.2 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
145.6B USD | 25.2 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
112.9B USD | 13.5 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR | 14 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.4B USD | 13 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD | 24.3 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.3B USD | 33.5 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
287.7B CNY | 22.7 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
NO |
![]() |
Medistim ASA
OSE:MEDI
|
Average EV/EBITDA:
26
21.9
|
7%
|
3.1 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
22.5
|
13%
|
1.7 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
60.9
|
24%
|
2.5 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
34.2
|
21%
|
1.6 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
25.2
|
12%
|
2.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
13.5
|
7%
|
1.9 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
13
|
11%
|
1.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
24.3
|
12%
|
2 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
33.5
|
12%
|
2.8 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
22.7
|
16%
|
1.4 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.